Veristat and Catalyst Join Forces To Give You The Right Regulatory Guidance

Creating a unique and unrivaled team of regulatory experts who develop and implement regulatory strategies, applications, submissions, and interactions with regulatory agencies around the globe.

Helping clients develop and pursue the right regulatory pathway for their clinical program requires years of experience, expertise with agency interactions and a proven history of success.  This is why Veristat and Catalyst Regulatory Services have joined forces.  The combination provides  biopharmaceutical companies with the guidance obtain and maintain their regulatory applications along the pathway to market approval.

Veristat, a full-service CRO has acquired Catalyst to strengthen its existing Regulatory Affairs, Operations, and Consulting expertise. Catalyst brings a core team of prominent Regulatory Strategists including senior experts with 25+ years of experience, an ex-FDA expert, additional CMC experts, and expanded European agency experience.   The newly expanded team will continue under the leadership of Mark Ammann, Pharm.D., former President of Catalyst Regulatory Services, LLC., and the newly appointed Senior Vice President, of Regulatory Affairs at Veristat.  Both Veristat and Catalyst clients will benefit from the collective intellectual expertise and capabilities offered by this prestigious team of senior regulatory experts.